[11C]MNPA

N/A

Report date: 2025/12/01 17:52:09
NME

Base Information

Drug Name[11C]MNPA
Drug Alias Name[11C]MNPA
ClassificationRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionDopamine D3 receptor agonistsDopamine D2 receptor agonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of HealthRijksuniversiteit Groningen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthRijksuniversiteit Groningen
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksN/A